chr11-88294225-A-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001814.6(CTSC):​c.1173T>G​(p.Thr391Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0492 in 1,613,914 control chromosomes in the GnomAD database, including 2,639 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.058 ( 293 hom., cov: 32)
Exomes 𝑓: 0.048 ( 2346 hom. )

Consequence

CTSC
NM_001814.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.56
Variant links:
Genes affected
CTSC (HGNC:2528): (cathepsin C) This gene encodes a member of the peptidase C1 family and lysosomal cysteine proteinase that appears to be a central coordinator for activation of many serine proteinases in cells of the immune system. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate heavy and light chains that form a disulfide-linked dimer. A portion of the propeptide acts as an intramolecular chaperone for the folding and stabilization of the mature enzyme. This enzyme requires chloride ions for activity and can degrade glucagon. Defects in the encoded protein have been shown to be a cause of Papillon-Lefevre syndrome, an autosomal recessive disorder characterized by palmoplantar keratosis and periodontitis. [provided by RefSeq, Nov 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 11-88294225-A-C is Benign according to our data. Variant chr11-88294225-A-C is described in ClinVar as [Benign]. Clinvar id is 258189.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.56 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0973 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CTSCNM_001814.6 linkc.1173T>G p.Thr391Thr synonymous_variant Exon 7 of 7 ENST00000227266.10 NP_001805.4 P53634-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CTSCENST00000227266.10 linkc.1173T>G p.Thr391Thr synonymous_variant Exon 7 of 7 1 NM_001814.6 ENSP00000227266.4 P53634-1

Frequencies

GnomAD3 genomes
AF:
0.0583
AC:
8862
AN:
151982
Hom.:
295
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0700
Gnomad AMI
AF:
0.0242
Gnomad AMR
AF:
0.0719
Gnomad ASJ
AF:
0.00548
Gnomad EAS
AF:
0.105
Gnomad SAS
AF:
0.0843
Gnomad FIN
AF:
0.0917
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0414
Gnomad OTH
AF:
0.0436
GnomAD2 exomes
AF:
0.0627
AC:
15739
AN:
250872
AF XY:
0.0621
show subpopulations
Gnomad AFR exome
AF:
0.0699
Gnomad AMR exome
AF:
0.0878
Gnomad ASJ exome
AF:
0.00706
Gnomad EAS exome
AF:
0.0895
Gnomad FIN exome
AF:
0.0946
Gnomad NFE exome
AF:
0.0406
Gnomad OTH exome
AF:
0.0461
GnomAD4 exome
AF:
0.0482
AC:
70506
AN:
1461814
Hom.:
2346
Cov.:
32
AF XY:
0.0487
AC XY:
35436
AN XY:
727206
show subpopulations
Gnomad4 AFR exome
AF:
0.0664
AC:
2224
AN:
33480
Gnomad4 AMR exome
AF:
0.0845
AC:
3776
AN:
44696
Gnomad4 ASJ exome
AF:
0.00708
AC:
185
AN:
26136
Gnomad4 EAS exome
AF:
0.129
AC:
5106
AN:
39700
Gnomad4 SAS exome
AF:
0.0932
AC:
8042
AN:
86250
Gnomad4 FIN exome
AF:
0.0915
AC:
4889
AN:
53420
Gnomad4 NFE exome
AF:
0.0391
AC:
43480
AN:
1111968
Gnomad4 Remaining exome
AF:
0.0439
AC:
2649
AN:
60396
Heterozygous variant carriers
0
4269
8539
12808
17078
21347
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
1758
3516
5274
7032
8790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0584
AC:
8880
AN:
152100
Hom.:
293
Cov.:
32
AF XY:
0.0614
AC XY:
4563
AN XY:
74320
show subpopulations
Gnomad4 AFR
AF:
0.0700
AC:
0.0700005
AN:
0.0700005
Gnomad4 AMR
AF:
0.0722
AC:
0.0722324
AN:
0.0722324
Gnomad4 ASJ
AF:
0.00548
AC:
0.0054755
AN:
0.0054755
Gnomad4 EAS
AF:
0.105
AC:
0.10462
AN:
0.10462
Gnomad4 SAS
AF:
0.0846
AC:
0.0846154
AN:
0.0846154
Gnomad4 FIN
AF:
0.0917
AC:
0.0917188
AN:
0.0917188
Gnomad4 NFE
AF:
0.0414
AC:
0.0413799
AN:
0.0413799
Gnomad4 OTH
AF:
0.0455
AC:
0.0455408
AN:
0.0455408
Heterozygous variant carriers
0
423
846
1270
1693
2116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0410
Hom.:
249
Bravo
AF:
0.0556
Asia WGS
AF:
0.102
AC:
352
AN:
3478
EpiCase
AF:
0.0365
EpiControl
AF:
0.0317

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 05, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Papillon-Lefèvre syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Haim-Munk syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Papillon-Lefèvre syndrome;C1855627:Haim-Munk syndrome;C4551681:Periodontitis, aggressive 1 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
2.1
DANN
Benign
0.65
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs17594; hg19: chr11-88027393; COSMIC: COSV57056951; COSMIC: COSV57056951; API